MedTrace Logo

Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization

NCT06219044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-01-23

No results posted yet for this study

Summary

PURPOSE OF THE STUDY The study aims to evaluate the effectiveness of the Dual Wavelength Laser System (DWLS) diode laser on the treatment of endometrioma (OMA), with ablation and vaporization of the cystic capsule without performing the stripping technique, in terms of ovarian reserve and recurrence rate.

Conditions

  • Endometrioma
  • Ovarian Endometriosis
  • Ovarian Endometrioma

Interventions

PROCEDURE

laparoscopic endometrioma laser vaporization

laser vaporization of ovarian endometrioma using a DWLS diode laser during a laparoscopy

Sponsors & Collaborators

  • University of Foggia

    collaborator OTHER

  • Azienda Ospedaliera per l'Emergenza Canizzaro

    collaborator OTHER

  • University of Cagliari

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-03-01
Completion
2023-09-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06219044 on ClinicalTrials.gov